Filter
1484
Filtered Results: 1484
Text search:
vaccine
trial
Featured
Recommendations
176
New Publications
334
Language
Document type
No document type
665
Studies & Reports
281
Guidelines
253
Manuals
86
Fact sheets
72
Strategic & Response Plan
64
Situation Updates
20
Training Material
16
Resource Platforms
12
Infographics
7
Videos
5
Brochures
2
App
1
Countries / Regions
Global
72
India
43
Sierra Leone
35
Liberia
35
Kenya
34
Nigeria
29
South Africa
28
Ethiopia
24
Western and Central Europe
22
Uganda
21
West and Central Africa
20
Latin America and the Carribbean
19
East and Southern Africa
18
Brazil
18
Africa
17
Guinea
16
Congo, Democratic Republic of
15
Russia
14
Ukraine
13
Ghana
13
Zambia
13
Rwanda
12
Bangladesh
12
Eastern Europe
12
Nepal
10
Malawi
10
Tanzania
10
Germany
10
South Sudan
10
Syria
9
Zimbabwe
9
Philippines
9
Mozambique
9
Cambodia
9
South–East Asia Region
9
Myanmar / Burma
9
Middle East and North Africa
8
Namibia
7
Senegal
6
Asia
6
Burkina Faso
5
Eastern Europe and Central Asia
5
Vietnam
5
Lesotho
4
Haiti
4
Central African Republic
4
Botswana
4
Indonesia
4
Thailand
3
China
3
Chile
3
Cameroon
3
Laos
3
USA
3
Paraguay
3
United Kingdom
3
Lebanon
3
Yemen
3
Angola
3
Turkey
2
Peru
2
Guinea-Bissau
2
Venezuela
2
Jordan
2
Spain
2
Côte d’Ivoire / Ivory Coast
2
Argentina
2
Papua New Guinea
2
Sudan
2
Chad
2
Madagascar
2
Tajikistan
1
Mexico
1
El Salvador
1
Benin
1
Gambia
1
Iran
1
Albania
1
Kyrgyzstan
1
Niger
1
Malaysia
1
Morocco
1
Bulgaria
1
Italy
1
Western Pacific Region
1
Gabon
1
Japan
1
Denmark
1
France
1
Tunisia
1
Portugal
1
Southern Africa
1
Moldova
1
Honduras
1
Mali
1
Iraq
1
Somalia
1
Ecuador
1
Eswatini/ Swaziland
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
429
Clinical Guidelines
174
Women & Child Health
79
Public Health
76
Key Resources
41
Pharmacy & Technologies
21
Capacity Building
8
Toolboxes
COVID-19
319
HIV
112
TB
112
Ebola & Marburg
85
NTDs
73
AMR
61
Rapid Response
59
Pharmacy
35
Mental Health
25
Health Financing Toolbox
23
Global Health Education
22
Planetary Health
21
Conflict
21
Refugee
19
Caregiver
15
NCDs
14
Cholera
13
Polio
13
Zika
12
Natural Hazards
5
Disability
5
Specific Hazards
4
Malaria
2
Learn what scientists look for in the different phases of a clinical trial for a vaccine. What does it mean when a vaccine trial is halted due to an adverse event? WHO’s Dr Kate O’Brien explains in Science in 5 this week
Document No. : FDA/SMC/CTD/GL-CCT/2013/01
The conduct of COVID-19 vaccine trials in the context of a candidate vaccine being issued with Emergency Use Designation raises challenging ethical questions, including in relation to the use of placebo controls and unblinding of trial participants in current and future COVID-19 vaccine trials. This...
August 2020, The Africa Joint Continental Strategy for COVID-19 is underpinned by the need to limit transmission, prevent deaths and reduce associated harms. Participation by African nations in clinical trials is an essential step to ensure that sufficient data is generated on the safety and efficac...
the Lancet : Published Online July 31, 2015 http://dx.doi.org/10.1016/S0140-6736(15)61117-5
The Lancet. Published Online December 22, 2016 http://dx.doi.org/10.1016/S0140-6736(16)32621-6. Open Access
The Lancet, Early Online Publication, 11 July 2014
doi:10.1016/S0140-6736(14)60934-X
*Free registration is required to view this article
Published:February 02, 2021DOI:https://doi.org/10.1016/S0140-6736(21)00234-8
The roadmap describes the actions needed to
achieve the three development goals for TB
vaccines set by the WHO:
1. A safe, effective and affordable TB vaccine
for adolescents and adults.
2. An affordable TB vaccine for neonates and
infants with improved safety and efficacy.
3. A therapeutic v...
The report presents current information (updated to September 2015) on candidate vaccines, therapies and medical devices for Ebola and gives an overview of completed and on-going trials.
COVID-19 vaccine tracker and landscape
recommended
The COVID-19 vaccine tracker and landscape compiles detailed information of each COVID-19 vaccine candidate in development by closely monitoring their progress through the pipeline.
The COVID-19 vaccine tracker:
Provides summary tables of COVID-19 vaccine candidates in both clinical and pre-...
This document is part three in a series of explainers on vaccine development and distribution. Part one focused on how vaccines work to protect our bodies from disease-carrying germs. Part two focused on the ingredients in a vaccine and the three clinical trial phases.
This document outlines the...
This article is part two in a series of explainers on vaccine development and distribution. Part one focused on how vaccines work to protect our bodies from disease-carrying germs. This article focuses on the ingredients in a vaccine and the three clinical trial phases. Part three outlines the nex...
This article is part four in a series of explainers on vaccine development and distribution.
Part one focused on how vaccines work to protect our bodies from disease-carrying germs.
Part two focused on the ingredients in a vaccine and the three clinical trial phases.
Part three focused on the ste...
Exciting news this week with @Pfizer reporting their mRNA vaccine is 90% effective, based on their Phase III clinical trial data. Dr. Tom looks inside the virus to break down how mRNA vaccines work, and whether news this promising means we can finally relax.
Manufacturers:
SK Bioscience Co. Ltd. [COVID-19 Vaccine (ChAdOx1-S [recombinant])]
Serum Institute of India Pvt. Ltd. [COVISHIELD™, ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant)]
Efficacy shown in clinical trials in participants who received the full series of vaccine (2 doses) ir...
10 May 2021. Manufactureres:
SK Bioscience Co. Ltd. [COVID-19 Vaccine (ChAdOx1-S [recombinant])]
Serum Institute of India Pvt. Ltd. [COVISHIELD™, ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant)]
The ChAdOx1-S/nCoV-19 [recombinant] vaccine is a replication-deficient adenoviral vecto...
Early data from US biotech Moderna has revealed that its Covid-19 vaccine candidate is 94.5 per cent effective, raising hopes that a range of immunisations will be available to help end the pandemic.
The interim analysis of the vaccine, currently known as mRNA-1273, comes after 95 trial particip...
